Both in Pharmaceuticals
First Tracks Biotherapeutics vs Sarepta Therapeutics,
Over the past year TRAX returned +25.5% and SRPT returned −5.5%; their daily moves had a correlation of 0.70.
TRAX +25.5% SRPT −5.5%Growth of $1, one year, split-adjusted
| Metric | TRAX | SRPT |
|---|---|---|
| Price | $45.72 | $19.32 |
| Market cap | $1.92B | $2.04B |
| Today | +0.75% | +2.28% |
| 1 month | +27.1% | +3.6% |
| 6 months | — | −6.5% |
| Year to date | — | −10.2% |
| 1 year | — | −17.8% |
| Revenue growth (YoY) | — | −34.3% |
| Gross margin | — | 62.8% |
| Net margin | — | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.0× |
| Net cash | $168.0M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 63.3% |
| Short % of float | 21.3% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).